Patients with inflammatory bowel disease (IBD) who develop COVID-19 should stop taking thiopurines, methotrexate, tofacitinib, and biological therapies during the viral illness, according to the AGA.
from WebMD Health https://www.webmd.com/lung/news/20200413/ibd-and-covid-19-hold-certain-meds-aga-advises?src=RSS_PUBLIC
0 Comments:
Post a Comment